MedPath

The Effect of Cognitive Behavioral Program based on an Interactive Application on Serum Glucose Level and HbA1C of Family member of Patients with Type 2 diabetes

Not Applicable
Conditions
Blood Glucose and HbA1c.
Elevated blood glucose level
Registration Number
IRCT20111203008286N10
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
20
Inclusion Criteria

Ages 30 to 60 years
BMI<35
No history of diabetes or cardiovascular disease
No pregnancy or breastfeeding
Ability to do physical activity (walking)
Ability to speak Persian
Do not suffer from severe mental illness
Do not have cognitive disorders such as dementia and Alzheimer's
Do not take anti-diabetic and anti-obesity drugs
Willingness to participate in the study
Waist circumference equal to or greater than 102 cm for men and 88 cm for women
Blood sugar equal to or greater than 100 mg / dL
Systolic blood pressure greater than or equal to 130 and diastolic blood pressure greater than or equal to 85 mm Hg
Have three of the 5 American Heart Association criteria for Metabolic Syndrome,

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alteration in HbA1C level in during one-year follow-up. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed.(High-performance liquid chromatography).;Fasting plasma glucose in during one-year follow-up. Timepoint: At onset and 6 and 12 months after onset. Method of measurement: Go to the lab, that they are informed.(With the autoanalyzer approach and with Pars test kits).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath